Service information checked on 5 August 2026. Local availability may change, so patients should consult NHS Wales or their health board before attending.
Wales reached an important women’s-health milestone in March 2026, when the Welsh Government announced that every health board had launched a women’s health hub pathfinder.
The word “hub”, however, does not mean the same thing in every part of Wales.
Some hubs are physical clinics, while others are online information and signposting services. Some cover a broad range of menstrual-health, contraception and menopause concerns, while others initially serve a particular area, age group or group of GP practices. Access may be direct, referral-based or limited to patients who meet local criteria.
There have also been changes since the national launch. Betsi Cadwaladr University Health Board has said that its initial Llandudno pathfinder ended on 31 March 2026 and is not currently offering appointments. Hywel Dda University Health Board has said that its Aberystwyth pilot is temporarily paused and is expected to be re-established later in 2026.
The accurate message, therefore, is not that seven identical one-stop clinics are permanently open across Wales. It is that every health board launched a locally designed pathfinder under the national programme, and that patients need to check what is currently available in their area.
What sits behind the hubs
The hubs are one of the first major commitments in the NHS Wales Women’s Health Plan, a ten-year programme running from 2025 to 2035.
The plan contains 64 actions across eight priority areas, including menstrual health, endometriosis and adenomyosis, contraception, pelvic health, menopause, preconception health, violence against women and girls, and ageing well with long-term conditions. It was informed by the experiences of around 4,000 women in Wales.
The programme also includes investment in women’s-health research. A £750,000 funding call was established for dedicated research projects, while more than £3 million was secured for the Women’s Health Research Wales centre of excellence. Each health board also received £300,000 to develop its initial hub pathfinder.
The original target—to launch a pathfinder in every health-board area by the end of March 2026—was met on schedule. That is a meaningful delivery milestone, but it is not yet proof that access has improved consistently or that every local service is sustainable.
The more important test will be what remains available after the pathfinder stage, whether services expand beyond limited pilot populations and whether patients experience shorter waits, fewer repeated referrals and better care.
What does a women’s health hub actually look like?
The differences between areas are significant.
Cwm Taf Morgannwg’s hub at Ysbyty Cwm Cynon provides face-to-face and virtual support concerning menstrual health, contraception and menopause, generally following a GP referral.
Swansea Bay’s current hub is principally an online portal that brings together information and links to existing services.
Cardiff and Vale’s first pathfinder is a menopause service initially covering women aged 40 to 65 who are registered with four GP practices in East Cardiff.
This local flexibility may help health boards respond to the needs of their populations, but it also makes the term “hub” potentially confusing. A resident may reasonably expect a physical clinic offering direct access to several specialists, when the local service is actually an information website or a limited pilot.
Patients should therefore check whether their local hub is physical or online, which conditions it covers, whether it is currently operating and whether a referral is required.
Menopause and the proposed HRT review
The plan’s menopause commitments include reviewing prescribing practices relating to hormone replacement therapy, developing community menopause champions and supporting further research.
“The menopause conversation has changed substantially in a relatively short period,” says Ana Carolina Goncalves, Superintendent Pharmacist at Pharmica online pharmacy.
“Current guidance supports HRT as an effective option for symptoms such as hot flushes and night sweats, but its benefits and risks still need to be considered for the individual. The discussion should not be reduced to the idea that HRT is either universally good or universally bad.
“Women have also had to contend with changing public information and periods of medicine-supply disruption. Reviewing prescribing practice creates an opportunity to identify variation, determine whether it is clinically justified and make sure that conversations reflect current evidence and guidance.”
NICE recommends offering HRT for vasomotor symptoms associated with menopause, while tailoring the discussion to the person’s age, medical history, circumstances, preferences and individual risk factors.
The most appropriate treatment can depend on several factors, including whether someone has a uterus, the symptoms they are experiencing, their personal and family medical history, and the type and route of HRT being considered.
A national prescribing review should help establish where practice differs, whether those differences are clinically appropriate and where clinicians or patients need better decision-support.
Community menopause champions could also help people recognise possible symptoms, find reliable information and feel better prepared before approaching a healthcare professional. Their effectiveness will ultimately depend on their training, role and connection to local clinical services.
Contraception and the need for reliable information
The plan’s contraception actions include improving online information, collecting better data and increasing professional training in methods such as intrauterine devices and systems, commonly called coils.
Fitting a coil requires specific clinical training and maintained competence, and not every GP practice provides the procedure. Patients may instead be referred to another practice or a sexual-health service, and local waiting times can vary.
Increasing the number of appropriately trained clinicians could improve access to long-acting reversible contraception. Training alone, however, will not remove every barrier. Services also need suitable facilities, appointments, funding and protected clinical time.
The commitment to better online information is equally important.
Many people look up symptoms or treatment options before—or alongside—speaking to a healthcare professional. Good information can help someone understand their choices, recognise when they need care and prepare useful questions. Poor information can leave them with outdated, oversimplified or commercially influenced claims.
“Reliable online information is one of the commitments I would watch closely,” says Goncalves.
“Many people research period symptoms, contraception or menopause before speaking to a clinician, and the quality of what they find can shape their expectations and decisions.
“Period delay, contraception and menopause are all areas where people can arrive having absorbed fragments of information without the context needed to apply it safely. Good digital information does not replace an individual assessment, but it can make the first clinical conversation considerably more useful.”
Menstrual health and making every contact count
The plan also includes a “Make Every Contact Count” commitment. This encourages clinicians to consider menstrual health and menopause during appropriate existing healthcare contacts, rather than relying entirely on the patient to raise the subject.
That may matter because symptoms such as severe period pain, heavy bleeding or disruptive menopause symptoms can be normalised, endured for long periods or left unmentioned when an appointment was originally booked for something else.
Being asked an appropriate question can create an opportunity to identify a concern earlier and direct someone towards the right service.
This should still be done sensitively. It should not become an indiscriminate checklist, intrude on the patient’s privacy or distract from the immediate reason for the consultation.
What people in Wales can do now
The first practical step is to visit the NHS Wales Women’s Health website and use its local-support search.
Do not assume that your local “hub” is a walk-in clinic. Check:
- whether it is a physical service or an online information hub;
- which aspects of women’s health it covers;
- whether it is currently accepting patients;
- whether you can contact it directly; and
- whether a GP or another healthcare professional must refer you.
NHS prescriptions dispensed in Wales are free for people registered with a Welsh GP. Welsh residents who are registered with a GP in England may require an entitlement card. Private prescriptions and medicines purchased outside an NHS service are not automatically free.
Community pharmacies may also be able to help without a GP appointment.
Wales’s Common Ailments Service currently provides free NHS advice and, where clinically appropriate, treatment for 28 common conditions through participating pharmacies. The pharmacist may provide treatment, self-care advice or referral depending on the person’s symptoms and clinical suitability.
Some pharmacies also offer services such as contraception, sore-throat assessment, urinary-tract-infection treatment or pharmacist independent prescribing. The precise services and appointment arrangements vary by pharmacy.
In March 2026, the first cohort of pharmacists educated under the reformed training programme entered the Welsh workforce able to register as independent prescribers from the beginning of their careers.
That should increase prescribing capacity over time, but it does not mean every pharmacist can immediately diagnose or prescribe for every condition. Pharmacists must still work within their competence, local governance arrangements and the NHS services commissioned at their workplace.
Although the programme is described as women’s health, NHS Wales also recognises that trans men and non-binary people may need access to relevant menstrual, reproductive and menopause services. Local care should be appropriate and sensitive to everyone who needs it.
The honest assessment
Launching a pathfinder in every health-board area was a genuine milestone.
It established a national structure, attracted dedicated funding and made menopause, contraception and menstrual health visible priorities within the Welsh NHS.
It is still too early to describe the programme as a completed solution.
The local models range from multidisciplinary clinical services to online information portals. Some cover only part of a health-board population, some require referral and at least two initial pilots have paused since the March announcement.
That does not necessarily mean the programme has failed. The purpose of a pathfinder is to test, evaluate and refine a proposed model. It does mean that “seven hubs” should not be interpreted as seven equivalent, permanent clinics offering the same care.
The programme should ultimately be judged by whether services remain sustainably funded, expand beyond limited pilot populations and improve patients’ experiences. Relevant measures should include waiting times, repeated referrals, geographical inequalities, access for underserved communities and whether patients feel listened to and receive appropriate care sooner.
For now, the most useful message is simple: Wales has launched the framework for a new approach to women’s healthcare, but the service available to an individual depends heavily on where they live.
Check the NHS Wales website and the relevant health board before assuming what your local hub provides.
